These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 18025108

  • 1. Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35.
    Shi J, Hu Z, Pabon K, Scotto KW.
    Mol Cell Biol; 2008 Jan; 28(2):883-95. PubMed ID: 18025108
    [Abstract] [Full Text] [Related]

  • 2. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú, Puche JE, Hannivoort R, Lang UE, Cohen-Naftaly M, Friedman SL.
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [Abstract] [Full Text] [Related]

  • 3. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.
    Merdzhanova G, Edmond V, De Seranno S, Van den Broeck A, Corcos L, Brambilla C, Brambilla E, Gazzeri S, Eymin B.
    Cell Death Differ; 2008 Dec; 15(12):1815-23. PubMed ID: 18806759
    [Abstract] [Full Text] [Related]

  • 4. Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35.
    Apostolatos H, Apostolatos A, Vickers T, Watson JE, Song S, Vale F, Cooper DR, Sanchez-Ramos J, Patel NA.
    J Biol Chem; 2010 Aug 20; 285(34):25987-95. PubMed ID: 20547768
    [Abstract] [Full Text] [Related]

  • 5. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
    Chang JG, Yang DM, Chang WH, Chow LP, Chan WL, Lin HH, Huang HD, Chang YS, Hung CH, Yang WK.
    PLoS One; 2011 Aug 20; 6(6):e18643. PubMed ID: 21694768
    [Abstract] [Full Text] [Related]

  • 6. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes.
    Lu GY, Huang SM, Liu ST, Liu PY, Chou WY, Lin WS.
    Int J Biochem Cell Biol; 2014 Feb 20; 47():83-92. PubMed ID: 24333670
    [Abstract] [Full Text] [Related]

  • 7. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
    Yea S, Narla G, Zhao X, Garg R, Tal-Kremer S, Hod E, Villanueva A, Loke J, Tarocchi M, Akita K, Shirasawa S, Sasazuki T, Martignetti JA, Llovet JM, Friedman SL.
    Gastroenterology; 2008 May 20; 134(5):1521-31. PubMed ID: 18471523
    [Abstract] [Full Text] [Related]

  • 8. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
    Liang WC, Wang Y, Xiao LJ, Wang YB, Fu WM, Wang WM, Jiang HQ, Qi W, Wan DC, Zhang JF, Waye MM.
    RNA Biol; 2014 May 20; 11(7):845-54. PubMed ID: 24921656
    [Abstract] [Full Text] [Related]

  • 9. Suppression of 5' splice-sites through multiple exonic motifs by hnRNP L.
    Loh TJ, Choi N, Moon H, Jang HN, Liu Y, Zhou J, Zheng X, Shen H.
    Biochim Biophys Acta Gene Regul Mech; 2017 Mar 20; 1860(3):363-373. PubMed ID: 28119102
    [Abstract] [Full Text] [Related]

  • 10. Splicing factor SC35 promotes tau expression through stabilization of its mRNA.
    Qian W, Iqbal K, Grundke-Iqbal I, Gong CX, Liu F.
    FEBS Lett; 2011 Mar 23; 585(6):875-80. PubMed ID: 21333649
    [Abstract] [Full Text] [Related]

  • 11. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A, Martignetti JA, Narla G.
    Drug Resist Updat; 2009 Mar 23; 12(1-2):1-7. PubMed ID: 19097929
    [Abstract] [Full Text] [Related]

  • 12. TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.
    Botella LM, Sanz-Rodriguez F, Komi Y, Fernandez-L A, Varela E, Garrido-Martin EM, Narla G, Friedman SL, Kojima S.
    Biochem J; 2009 Apr 15; 419(2):485-95. PubMed ID: 19076057
    [Abstract] [Full Text] [Related]

  • 13. Antagonistic factors control the unproductive splicing of SC35 terminal intron.
    Dreumont N, Hardy S, Behm-Ansmant I, Kister L, Branlant C, Stévenin J, Bourgeois CF.
    Nucleic Acids Res; 2010 Mar 15; 38(4):1353-66. PubMed ID: 19965769
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
    Wang J, Manley JL.
    RNA; 1995 May 15; 1(3):335-46. PubMed ID: 7489505
    [Abstract] [Full Text] [Related]

  • 15. Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor gene.
    Sureau A, Soret J, Guyon C, Gaillard C, Dumon S, Keller M, Crisanti P, Perbal B.
    Nucleic Acids Res; 1997 Nov 15; 25(22):4513-22. PubMed ID: 9358160
    [Abstract] [Full Text] [Related]

  • 16. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
    Loh TJ, Moon H, Cho S, Jung DW, Hong SE, Kim DH, Green MR, Zheng X, Zhou J, Shen H.
    Oncol Rep; 2014 Jan 15; 31(1):273-9. PubMed ID: 24173428
    [Abstract] [Full Text] [Related]

  • 17. SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA.
    Meshorer E, Bryk B, Toiber D, Cohen J, Podoly E, Dori A, Soreq H.
    Mol Psychiatry; 2005 Nov 15; 10(11):985-97. PubMed ID: 16116489
    [Abstract] [Full Text] [Related]

  • 18. Several mRNAs with variable 3' untranslated regions and different stability encode the human PR264/SC35 splicing factor.
    Sureau A, Perbal B.
    Proc Natl Acad Sci U S A; 1994 Feb 01; 91(3):932-6. PubMed ID: 8302870
    [Abstract] [Full Text] [Related]

  • 19. The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis.
    Gabut M, Miné M, Marsac C, Brivet M, Tazi J, Soret J.
    Mol Cell Biol; 2005 Apr 01; 25(8):3286-94. PubMed ID: 15798212
    [Abstract] [Full Text] [Related]

  • 20. Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional Mechanisms.
    Shi J, Pabon K, Scotto KW.
    J Biol Chem; 2015 Jun 12; 290(24):14986-5003. PubMed ID: 25818199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.